Diabetes Mellitus Type 2 Disease

BASICS

DESCRIPTION
Non-ketosis prone hyperglycemia and glucose intolerance due to defects in insulin secretion and peripheral insulin action. Accounts for 80% of diabetic cases.
  • System(s) affected: Endocrine/Metabolic, Nervous, Renal/Urologic, Cardiovascular
  • Genetics: Strong polygenic familial susceptibility. Concordance is nearly complete in identical twins.
  • Incidence/Prevalence in USA:
    • Incidence:
      • 300/100,000 (males 230/100,000, females 340/100,000)
    • Prevalence:
      • 5,000/100,000
      • More common in some groups such as Pima Indians with 35% prevalence
  • Predominant age: Typically occurs after age 40
  • Predominant sex: Female > Male in Caucasian populations
SIGNS AND SYMPTOMS
  • Related to hyperglycemia and complications including nephropathy, neuropathy, and retinopathy
  • Polyuria
  • Polydipsia
  • Polyphagia
  • Weight loss
  • Weakness
  • Fatigue
  • Frequent infections
CAUSES
Genetic factors and obesity are important
RISK FACTORS
  • Family history
  • Gestational diabetes
  • Obesity

DIAGNOSIS

LABORATORY
Criteria for diagnosis
  • Symptoms of diabetes (polyuria, polydipsia, weight loss) plus casual (random) plasma glucose ≥ 200 mg/dL (11.1 mmol/L)
  • or
  • Fasting plasma glucose ≥ 126 mg/dL (7.0 mmol/L) on 2 occasions
  • or
  • 2 hour plasma glucose ≥ 200 mg/dL (11.1 mmol/L) during OGTT with 75 g glucose load
Drugs that may alter lab results:
  • Pentamidine
  • Nicotinic acid
  • Glucocorticoids
  • Thyroid hormone
  • Diazoxide
  • Beta adrenergic agonists
  • Thiazides
  • Dilantin
  • Alpha-interferon
Disorders that may alter lab results: See Differential Diagnosis
PATHOLOGICAL FINDINGS
N/A
SPECIAL TESTS
  • Glucose tolerance test usually not necessary, except when diagnosing gestational diabetes
  • Hemoglobin A1C not recommended for diagnosis, but helpful in management
IMAGING
N/A
DIAGNOSTIC PROCEDURES

N/A

TREATMENT

APPROPRIATE HEALTH CARE

Regular outpatient follow-up except for complicating emergencies such as severe hyperglycemia, hyperosmolar coma, and severe infections

GENERAL MEASURES
  • Home monitoring of blood glucose
  • Regular examination for complications: retinopathy, neuropathy, nephropathy
SURGICAL MEASURES

N/A

ACTIVITY

Regular aerobic exercise can improve glucose tolerance and decrease medication requirements

DIET
  • American Diabetes Association (ADA) provides dietary recommendations for NIDDM. The emphasis is on achieving glucose, lipid, and blood pressure goals. Mild caloric restriction is recommended to achieve mild to moderate weight loss (5-10 kg).
  • Food choices are similar to Dietary Guidelines for Americans and the Food Guide Pyramid:
    • 10-20% of calories from protein
    • < 10% of calories each from saturated and polyunsaturated fat
    • Remainder of calories from monounsaturated fat and carbohydrates, depending on individual patient factors
    • Sugar is not specifically prohibited
PATIENT EDUCATION
  • Education is critical for patients with NIDDM. Include information on the disease, medication treatment, self-monitoring, foot care, physical activity and diet management
  • Support groups and classes certified by the ADA are recommended
  • The ADA has prepared numerous patient education materials (430 North Michigan Ave. Chicago, IL 60611 or contact local ADA affiliate listed in white pages of telephone directory)

FOLLOW UP

PREVENTION/AVOIDANCE

Avoidance of weight gain and obesity and maintenance of regular physical activity may prevent or delay NIDDM

POSSIBLE COMPLICATIONS
  • Appear to be due to effects of diabetes mellitus on arterial walls in one form or another
  • Peripheral neuropathy
  • Proliferative retinopathy
  • Nephropathy and chronic renal failure
  • Atherosclerotic cardiovascular and peripheral vascular disease
  • Hyperosmolar coma
  • Gangrene of extremities
  • Blindness
  • Glaucoma
  • Cataracts
  • Skin ulceration
  • Charcot joints
EXPECTED COURSE AND PROGNOSIS
  • Maintenance of normal blood sugar levels may delay or prevent complications of diabetes
  • In susceptible individuals, complications begin to appear 10-15 years after onset, but can be present at time of diagnosis since disease may go undetected for years

MISCELLANEOUS

ASSOCIATED CONDITIONS
  • Hypertension is common (strict control may retard renal complications)
  • Hyperlipidemia
  • Impotence
AGE-RELATED FACTORS

Pediatric: Occasional cases of nonketosis-prone diabetes mellitus have been seen in children
Geriatric: Common in the elderly and is a significant contributing factor to blindness, renal failure, and lower limb amputations
Others: Generally diagnosed after age 40

PREGNANCY

Diabetes can cause significant maternal complications and fetal wasting. Intensive management has improved the outcome dramatically.

OTHER NOTES

N/A

ABBREVIATIONS

NIDDM = Non-insulin dependent diabetes mellitus
ADA = American Diabetic Association

Clinical Investigations

ROLE OF HOMOEOPATHY

Copyright © 2025 Selkey. All Rights Reserved.